MRK is trading at $119.47, up 4.16%.
🟢 Merck & Company Inc is trading 4.16% up
Merck & Company Inc
Related News
MRK
Merck to Present Phase 3 Melanoma Data at ESMO, Following Trial Success
MRK
Merck’s Experimental Eye Drug Meets Trial Goal, but Raises Safety Concerns
MRK
Halozyme Wins Order Blocking Merck's Injectable Keytruda in Eight European Markets
MRK
🔴 Merck is trading 3.06% down today amid Vaxcyte’s positive Phase 3 VAX-31 results
MRK